01/29/2015 - 2:47pm

Cardinal Health increased full-year share earnings projections to a range of $4.28 to $4.38, in part driven by a faster-than-expected start for its generics sourcing venture with CVS Health.

01/28/2015 - 5:34pm

"During one of the sessions at the 2008 NACDS Regional Chain Conference, we projected onto the video screen some images of advertisements that NACDS was beginning to use in the Washington, D.C. area. Looking back, one of the things that I remember most was the boldness and strategic focus of the tagline: 'Pharmacies. The face of neighborhood healthcare.' With the 2015 edition of this meeting just days away, it is striking how far we have come!" writes NACDS president and CEO Steve Anderson in his latest blog post. 

01/28/2015 - 2:53pm

The House Energy and Commerce Committee on Tuesday released a discussion document in the 21st Century Cures initiative.

01/27/2015 - 1:43pm

Actavis on Monday agreed to acquire Auden Mckenzie Holdings for approximately $465.8 million in cash, plus a two-year royalty on a percentage of gross profits of one of Auden Mckenzie's products.

01/27/2015 - 12:01pm

Rep. Jason Chaffetz, R-Utah, last week introduced a bill that would extend to new combination drugs containing molecules already approved by the Food and Drug Administration the same five-year market exclusivity as a drug product containing an entirely new set of active ingredients.

01/27/2015 - 11:11am

Health and Human Services Secretary Sylvia Burwell announced goals and a timeline to move the Medicare program toward paying providers based on the quality of care they give patients.

 

01/27/2015 - 11:09am

Teva Pharmaceutical Industries announced that the Food and Drug Administration approved the company’s first generic Nexium delayed-release tablets in the United States.

01/27/2015 - 10:34am

The Food and Drug Administration on Monday announced approval for the first generic version of Nexium (esomeprazole magnesium delayed-release capsules), which are used to treat gastroesophageal reflux disease in adults and children ages 1 year and older.

01/22/2015 - 1:15pm

Camber Pharmaceuticals on Thursday announced the launch of pantoprazole sodium delayed-release tablets USP, the generic version of Pfizer's Protonix. The drug is used to treat gastro esophageal reflux disease and damage to the esophagus.